JoVE Logo

Sign In

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

13.7K Views

11:37 min

February 18th, 2015

DOI :

10.3791/52446-v

February 18th, 2015


Explore More Videos

Keywords Ovarian Cancer

Chapters in this video

0:05

Title

1:43

Multicellular Spheroid Generation from Ovarian Cancer Cell Lines

5:02

Cell Staining for Flow Cytometric Confirmation of Tumor-initiating Cells (TIC) Markers

7:39

Confirmation of Tumorigenicity by In vivo Subcutaneous Injections of TIC Cultures

9:03

Results: Low-attachment, Serum-free Conditions Enrich for Cells with TIC Markers and Tumorigenicity

11:06

Conclusion

Related Videos

article

08:54

In vitro Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis

14.4K Views

article

12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

15.0K Views

article

07:19

Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids

4.2K Views

article

05:58

Method for Obtaining Primary Ovarian Cancer Cells From Solid Specimens

13.4K Views

article

08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

12.2K Views

article

11:50

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

13.4K Views

article

05:35

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

1.4K Views

article

08:26

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

1.8K Views

article

08:39

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays

9.5K Views

article

07:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

2.5K Views

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved